4.6 (417) In stock
Figure 4 from Cannabinoid Discrimination and Antagonism by CB1 Neutral and Inverse Agonist Antagonists
Analysis of Tolerance and Behavioral/Physical Dependence during
Full article: A comprehensive patents review on cannabinoid 1
Effects of acute AM4113 (60-minute pretreatment time) on food and
Cells, Free Full-Text
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. - Abstract - Europe PMC
Effects of the cannabinoid CB1-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male rats - ScienceDirect
Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research
DDC, Free Full-Text